Hana Do
DATE/TIME September 19, 10:15 – 10:45 PM EST TITLE Characterizing How Sponsors are Transitioning from Onsite to Centralized and Risk-Based Monitoring Approaches SPEAKER Hana Do Research Analyst Tufts CSDD ABSTRACT This session presents the results of a new Tufts CSDD study looking at how companies have made, or are making, the transition from traditional, high […]
Linda Evans O’Connor
DATE/TIME September 19, 08:30 – 09:00 PM EST TITLE Inspection Intelligence: What the FDA Is Really Looking for Now SPEAKER Linda Evans O’Connor Vice President Lachman Consultants ABSTRACT In this session, Linda Evans O’Connor, Vice President at Lachman Consultants, will share insights into current FDA inspection trends and priorities, offering practical guidance for navigating evolving […]
Raj Joshi
DATE/TIME September 18, 01:30 – 02:00 PM EST TITLE Balancing Cost, Risk, and Quality in CDMO Selection SPEAKER Raj Joshi Head of Procurement Pacira Biosciences ABSTRACT Selecting a CDMO is one of the most important strategic decisions that an organization will make. A wrong selection can derail or jeopardize a company’s strategic plans and even […]
Navdeep Pahuja
DATE/TIME September 18, 11:20 – 12:00 PM EST TITLE The Future of Pharma Partnerships: Key Trends Shaping BD and Alliance Management SPEAKERS Navdeep Pahuja Senior Director of Business Development and M&A Dr. Reddy’s Laboratories Mayank Nagar Vice President and Head, Strategic Alliance Management & Tech Services, North America Generics Dr. Reddy’s Laboratories ABSTRACT Dr. Reddy’s […]
Firouz Asgarzadeh
DATE/TIME September 19, 9:30 – 10:00 AM EST TITLE Faster, Smarter Drug Development: The Role of AI, ML, and Robotics in Pharma and CDMO Innovation SPEAKER Firouz Asgarzadeh, President, OSD Pharmaceutical Solutions LLC ABSTRACT Of 10,000 drug candidates, only 250 reach preclinical studies, and just one is ultimately commercialized. On average, it takes 10 to […]
Eric Langer
DATE/TIME September 19, 09:00 – 09:30 AM EST TOPIC Biomanufacturing 2025: What’s Driving the Next Wave of Outsourcing Growth SPEAKER Eric Langer President and Managing Partner BioPlan Associates, Inc. ABSTRACT As the biomanufacturing landscape continues to evolve, outsourcing is playing an increasingly critical role in driving growth and innovation. This session will explore the key […]
Lisa Cozza
DATE/TIME September 18, 02:30 – 03:00 PM EST TITLE Beyond the Contract: Turning Partnerships into Performance Speaker Lisa Cozza, Principal Consultant, Tunnell Consulting ABSTRACT This session will explore how to maximize contract relationships from the selection phase all the way through maintenance and contract termination. Lisa will address post-contract challenges in managing partner relationships, including […]
Ben Locwin
DATE/TIME September 18, 9:20 – 10:00 AM EST TITLE Keynote: CDMO 2030: What the Next Generation of Sponsors Will Demand SPEAKER Ben Locwin, Vice President, Reliant Life Sciences ABSTRACT CDMOs are on one hand at the mercy of the market, and on the other hand helping to institutionalize and drive change across the entire industry. […]
Mayank Nagar
DATE/TIME September 18, 11:20 – 12:00 PM EST TITLE The Future of Pharma Partnerships: Key Trends Shaping BD and Alliance Management SPEAKERS Navdeep Pahuja Senior Director of Business Development and M&A Dr. Reddy’s Laboratories Mayank Nagar Vice President and Head, Strategic Alliance Management & Tech Services, North America Generics Dr. Reddy’s Laboratories ABSTRACT Dr. Reddy’s […]
David H. Windley
DATE/TIME September 18, 2:00 – 2:30 PM EST TITLE Normalization of the Pipeline: The Science vs. Funding Battle SPEAKER David H. Windley, CFA, CPA Managing Director, Jefferies LLC ABSTRACT Investment in innovation has moderated since the euphoric pandemic years. But the pandemic hangover is not the only issue with which the industry is contending. Inflation […]
